197 related articles for article (PubMed ID: 36123031)
1. Molecular Pathophysiology of Chronic Wounds: Current State and Future Directions.
Pastar I; Balukoff NC; Marjanovic J; Chen VY; Stone RC; Tomic-Canic M
Cold Spring Harb Perspect Biol; 2023 Apr; 15(4):. PubMed ID: 36123031
[TBL] [Abstract][Full Text] [Related]
2. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors.
Trengove NJ; Stacey MC; MacAuley S; Bennett N; Gibson J; Burslem F; Murphy G; Schultz G
Wound Repair Regen; 1999; 7(6):442-52. PubMed ID: 10633003
[TBL] [Abstract][Full Text] [Related]
4. The role of surgical debridement in healing of diabetic foot ulcers.
Gordon KA; Lebrun EA; Tomic-Canic M; Kirsner RS
Skinmed; 2012; 10(1):24-6. PubMed ID: 22324173
[TBL] [Abstract][Full Text] [Related]
5. Chronic non-healing wounds in geriatrics.
Mezera V; Bureš I
Vnitr Lek; 2018; 64(11):1098-1104. PubMed ID: 30606028
[TBL] [Abstract][Full Text] [Related]
6. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
Rai V; Moellmer R; Agrawal DK
Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
[TBL] [Abstract][Full Text] [Related]
7. Effect of a New Purified Collagen Matrix With Polyhexamethylene Biguanide on Recalcitrant Wounds of Various Etiologies: A Case Series.
Lintzeris D; Vernon K; Percise H; Strickland A; Yarrow K; White A; Gurganus M; Sherrod S; Vergin K; Johnson L
Wounds; 2018 Mar; 30(3):72-78. PubMed ID: 29584602
[TBL] [Abstract][Full Text] [Related]
8. Chronic Wounds: Evaluation and Management.
Bowers S; Franco E
Am Fam Physician; 2020 Feb; 101(3):159-166. PubMed ID: 32003952
[TBL] [Abstract][Full Text] [Related]
9. Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing.
Brem H; Balledux J; Bloom T; Kerstein MD; Hollier L
Arch Surg; 2000 Jun; 135(6):627-34. PubMed ID: 10843357
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of wound care management: (3) antimicrobial agents for chronic wounds; (4) diabetic foot ulceration.
O'Meara S; Cullum N; Majid M; Sheldon T
Health Technol Assess; 2000; 4(21):1-237. PubMed ID: 11074391
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy for chronic wounds.
Kranke P; Bennett M; Roeckl-Wiedmann I; Debus S
Cochrane Database Syst Rev; 2004; (2):CD004123. PubMed ID: 15106239
[TBL] [Abstract][Full Text] [Related]
12. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
Curran MP; Plosker GL
BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
[TBL] [Abstract][Full Text] [Related]
13. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds.
Loots MA; Lamme EN; Zeegelaar J; Mekkes JR; Bos JD; Middelkoop E
J Invest Dermatol; 1998 Nov; 111(5):850-7. PubMed ID: 9804349
[TBL] [Abstract][Full Text] [Related]
14. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine.
Andrews KL; Houdek MT; Kiemele LJ
Prosthet Orthot Int; 2015 Feb; 39(1):29-39. PubMed ID: 25614499
[TBL] [Abstract][Full Text] [Related]
15. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
16. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
17. Management of Chronic Wounds: Diagnosis, Preparation, Treatment, and Follow-up.
Gupta S; Andersen C; Black J; de Leon J; Fife C; Lantis Ii JC; Niezgoda J; Snyder R; Sumpio B; Tettelbach W; Treadwell T; Weir D; Silverman RP
Wounds; 2017 Sep; 29(9):S19-S36. PubMed ID: 28862980
[TBL] [Abstract][Full Text] [Related]
18. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review.
Nair H; Venkateshwaran N; Seetharaman S S; Deng W; Uthaipaisanwong A; Galea E
J Wound Care; 2021 Apr; 30(Sup4):S42-S52. PubMed ID: 33856929
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
[TBL] [Abstract][Full Text] [Related]
20. Approaches to Modulate the Chronic Wound Environment Using Localized Nucleic Acid Delivery.
Berger AG; Chou JJ; Hammond PT
Adv Wound Care (New Rochelle); 2021 Sep; 10(9):503-528. PubMed ID: 32496978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
